AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts

Akira Kondo(Gifu University), Haruhiko Tokuda(National Center for Geriatrics and Gerontology)
International Journal of Molecular Medicine
October 15, 2012
Cited by 11


Related Papers